SEC Form 4 · accession 0000875320-26-000272
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jasper van Grunsven
Officer — EVP, CP and NPPO
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2026 | A | 8,682 | $0.00 | A | 8,682 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock unit award that vests in installments beginning on 09/08/2027.